
orkambi
PrescriptionFDA-sourced
NewThe active ingredient in KALYDECO tablets and oral granules is ivacaftor, a cystic fibrosis transmembrane conductance regulator potentiator, which has the following chemical name: N -(2,4-di-tert-butyl-5-hydroxyphenyl)-1,4-dihydro-4-oxoquinoline-3-carboxamide.
cystic fibrosis transmembrane conductance regulator potentiatorcystic fibrosis